Literature DB >> 17513580

Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease.

Carlo G Rizzello1, Maria De Angelis, Raffaella Di Cagno, Alessandra Camarca, Marco Silano, Ilario Losito, Massimo De Vincenzi, Maria D De Bari, Francesco Palmisano, Francesco Maurano, Carmen Gianfrani, Marco Gobbetti.   

Abstract

Presently, the only effective treatment for celiac disease is a life-long gluten-free diet. In this work, we used a new mixture of selected sourdough lactobacilli and fungal proteases to eliminate the toxicity of wheat flour during long-time fermentation. Immunological (R5 antibody-based sandwich and competitive enzyme-linked immunosorbent assay [ELISA] and R5 antibody-based Western blot), two-dimensional electrophoresis, and mass spectrometry (matrix-assisted laser desorption ionization-time of flight, strong-cation-exchange-liquid chromatography/capillary liquid chromatography-electrospray ionization-quadrupole-time of flight [SCX-LC/CapLC-ESI-Q-TOF], and high-pressure liquid chromatography-electrospray ionization-ion trap mass spectrometry) analyses were used to determine the gluten concentration. Assays based on the proliferation of peripheral blood mononuclear cells (PBMCs) and gamma interferon production by PBMCs and intestinal T-cell lines (iTCLs) from 12 celiac disease patients were used to determine the protein toxicity of the pepsin-trypsin digests from fermented wheat dough (sourdough). As determined by R5-based sandwich and competitive ELISAs, the residual concentration of gluten in sourdough was 12 ppm. Albumins, globulins, and gliadins were completely hydrolyzed, while ca. 20% of glutenins persisted. Low-molecular-weight epitopes were not detectable by SCX-LC/CapLC-ESI-Q-TOF mass spectrometry and R5-based Western blot analyses. The kinetics of the hydrolysis of the 33-mer by lactobacilli were highly efficient. All proteins extracted from sourdough activated PBMCs and induced gamma interferon production at levels comparable to the negative control. None of the iTCLs demonstrated immunoreactivity towards pepsin-trypsin digests. Bread making was standardized to show the suitability of the detoxified wheat flour. Food processing by selected sourdough lactobacilli and fungal proteases may be considered an efficient approach to eliminate gluten toxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17513580      PMCID: PMC1932817          DOI: 10.1128/AEM.00260-07

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  43 in total

1.  In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.

Authors:  R P Anderson; P Degano; A J Godkin; D P Jewell; A V Hill
Journal:  Nat Med       Date:  2000-03       Impact factor: 53.440

2.  Glutenin is involved in the gluten-driven mucosal T cell response.

Authors:  Y van de Wal; Y M Kooy; P van Veelen; W Vader; S A August; J W Drijfhout; S A Peña; F Koning
Journal:  Eur J Immunol       Date:  1999-10       Impact factor: 5.532

Review 3.  Future therapeutic options for celiac disease.

Authors:  Ludvig M Sollid; Chaitan Khosla
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2005-03

4.  Intestinal T cell responses to cereal proteins in celiac disease.

Authors:  C Kilmartin; H Wieser; M Abuzakouk; J Kelly; J Jackson; C Feighery
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

5.  Molecular and functional characterization of Lactobacillus sanfranciscensis strains isolated from sourdoughs.

Authors:  M De Angelis; R Di Cagno; G Gallo; M Curci; S Siragusa; C Crecchio; E Parente; M Gobbetti
Journal:  Int J Food Microbiol       Date:  2007-01-16       Impact factor: 5.277

6.  Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease.

Authors:  R P Anderson; D A van Heel; J A Tye-Din; D P Jewell; A V S Hill
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

Review 7.  Activation-induced cell death in T cells and autoimmunity.

Authors:  Jian Zhang; Xuemei Xu; Yong Liu
Journal:  Cell Mol Immunol       Date:  2004-06       Impact factor: 11.530

8.  Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease.

Authors:  Dariusz Stepniak; Liesbeth Spaenij-Dekking; Cristina Mitea; Martine Moester; Arnoud de Ru; Renee Baak-Pablo; Peter van Veelen; Luppo Edens; Frits Koning
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-05-11       Impact factor: 4.052

9.  The toxicity of high molecular weight glutenin subunits of wheat to patients with coeliac disease.

Authors:  David H Dewar; Massimo Amato; H Julia Ellis; Emma L Pollock; Nuria Gonzalez-Cinca; Herbert Wieser; Paul J Ciclitira
Journal:  Eur J Gastroenterol Hepatol       Date:  2006-05       Impact factor: 2.566

10.  VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for Celiac Sprue.

Authors:  Maria De Angelis; Carlo G Rizzello; Alessio Fasano; Maria G Clemente; Claudio De Simone; Marco Silano; Massimo De Vincenzi; Ilario Losito; Marco Gobbetti
Journal:  Biochim Biophys Acta       Date:  2005-10-21
View more
  41 in total

1.  Selected lactic acid bacteria synthesize antioxidant peptides during sourdough fermentation of cereal flours.

Authors:  Rossana Coda; Carlo Giuseppe Rizzello; Daniela Pinto; Marco Gobbetti
Journal:  Appl Environ Microbiol       Date:  2011-12-09       Impact factor: 4.792

Review 2.  Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes.

Authors:  C Osorio; N Wen; R Gemini; R Zemetra; D von Wettstein; S Rustgi
Journal:  Funct Integr Genomics       Date:  2012-06-26       Impact factor: 3.410

Review 3.  Proteomic analyses lead to a better understanding of celiac disease: focus on epitope recognition and autoantibodies.

Authors:  Valli De Re; Maria Paola Simula; Vincenzo Canzonieri; Renato Cannizzaro
Journal:  Dig Dis Sci       Date:  2010-07-15       Impact factor: 3.199

4.  The sourdough fermentation may enhance the recovery from intestinal inflammation of coeliac patients at the early stage of the gluten-free diet.

Authors:  Maria Calasso; Olimpia Vincentini; Francesco Valitutti; Cristina Felli; Marco Gobbetti; Raffaella Di Cagno
Journal:  Eur J Nutr       Date:  2012-02-04       Impact factor: 5.614

5.  Long-Term Fungal Inhibition by Pisum sativum Flour Hydrolysate during Storage of Wheat Flour Bread.

Authors:  Carlo Giuseppe Rizzello; Anna Lavecchia; Valerio Gramaglia; Marco Gobbetti
Journal:  Appl Environ Microbiol       Date:  2015-04-10       Impact factor: 4.792

6.  Selected Probiotic Lactobacilli Have the Capacity To Hydrolyze Gluten Peptides during Simulated Gastrointestinal Digestion.

Authors:  Ruggiero Francavilla; Maria De Angelis; Carlo Giuseppe Rizzello; Noemi Cavallo; Fabio Dal Bello; Marco Gobbetti
Journal:  Appl Environ Microbiol       Date:  2017-06-30       Impact factor: 4.792

Review 7.  Celiac disease: prevalence, diagnosis, pathogenesis and treatment.

Authors:  Naiyana Gujral; Hugh J Freeman; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

Review 8.  The spectrum of celiac disease: epidemiology, clinical aspects and treatment.

Authors:  Greetje J Tack; Wieke H M Verbeek; Marco W J Schreurs; Chris J J Mulder
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-03-09       Impact factor: 46.802

9.  Enzymatic strategies to detoxify gluten: implications for celiac disease.

Authors:  Ivana Caputo; Marilena Lepretti; Stefania Martucciello; Carla Esposito
Journal:  Enzyme Res       Date:  2010-10-07

10.  Mechanism of degradation of immunogenic gluten epitopes from Triticum turgidum L. var. durum by sourdough lactobacilli and fungal proteases.

Authors:  Maria De Angelis; Angela Cassone; Carlo G Rizzello; Francesca Gagliardi; Fabio Minervini; Maria Calasso; Raffaella Di Cagno; Ruggero Francavilla; Marco Gobbetti
Journal:  Appl Environ Microbiol       Date:  2009-11-30       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.